Active substances
Caffeine + Ergotamine
- SFDA 1
- US FDA 7
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CAFERGOT 1 MG TAB | 1 , 100 mg | Tablet · Oral use | 20 Blister | SAR 16.30 | NCE · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MIGERGOT | 100MG;2MG | suppository · rectal | COSETTE | Prescription | 4 Oct 1983 |
| ERGOTAMINE TARTRATE AND CAFFEINE | 100MG;1MG | tablet · oral | PHARMOBEDIENT | Prescription | 16 Sep 2005 |
| CAFERGOT | 100MG;1MG | tablet · oral | NOVARTIS | Discontinued | 26 Nov 1948 |
| CAFERGOT | 100MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | suppository · rectal | NOVARTIS | Discontinued | 24 Apr 1953 |
| CAFERGOT | 100MG;1MG | tablet · oral | CHARTWELL RX | Discontinued | 29 Sep 1976 |
| WIGRAINE | 100MG;1MG | tablet · oral | ORGANON USA INC | Discontinued | 5 Nov 1980 |
| ERGOTAMINE TARTRATE AND CAFFEINE | 100MG;1MG | tablet · oral | HIKMA INTL PHARMS | Discontinued | 17 Sep 2004 |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.